SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001214659-21-012349
Filing Date
2021-11-29
Accepted
2021-11-29 13:00:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 j1129210sc13g.htm SC 13G 46190
  Complete submission text file 0001214659-21-012349.txt   47874
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87950 | Film No.: 211454821
SIC: 2834 Pharmaceutical Preparations

Mailing Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301
Business Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301 650-798-5495
TCG Crossover Management, LLC (Filed by) CIK: 0001839948 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G